Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Peramivir vs Oral Oseltamivir in Pediatric Acute Uncomplicated Influenza
NCT02369159Phase 3Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Mar 2015
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Mar 2015; status: completed.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02369159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369159.